CycloGen AI was founded by Linu Lawrence, an HPC architect and biomedical computing specialist with over 5 years of experience building GPU-accelerated infrastructure, AI pipelines, and computational platforms for biological research.
During his work supporting biomedical labs, Linu noticed a recurring challenge:
"Drug discovery tools were fragmented, slow, and required expert knowledge to operate. AI tools existed — but none were unified into a single intelligent platform."
Motivated to solve this, he began designing a new kind of molecular engineering engine — one capable of turning raw biological sequences into drug-ready molecules within minutes.
That vision became CycloGen AI.
Today, CycloGen AI integrates protein structure prediction, pocket analysis, binder engineering, ligand generation and triage, immuno-design, antiviral inhibitor design, real-time mutation scanning, and AI reasoning models — all in one seamless platform.
CycloGen AI empowers scientists, biotech startups, academic labs, and pharmaceutical teams to accelerate discovery, reduce costs, and design breakthrough therapeutics in silico.
To democratize molecular design by building the fastest, most intelligent, and most accessible AI-powered drug discovery platform on the planet.
A world where designing a new drug, antibody, antiviral, or therapeutic is as simple as writing a prompt — and just as fast.
Linu Lawrence
HPC Architect • Biomedical Computing Engineer • AI/ML Systems Builder
Expert in cluster architecture, Dockerized microservices, large-scale GPU pipelines, and end-to-end computational biology engines.